Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia

A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)

NCT00520572 ·Status: COMPLETED ·Phase: PHASE2

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis

NCT04507763 ·Status: COMPLETED

Brigham and Women's Rheumatoid Arthritis Sequential Study

NCT01793103 ·Status: ACTIVE_NOT_RECRUITING

Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD

NCT05936970 ·Status: RECRUITING

Electronic and Lab Pre-screening of New Rheumatology Patients With Rheumatoid Arthritis

NCT03843619 ·Status: UNKNOWN

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

NCT01981473 ·Status: COMPLETED

European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study

NCT01286545 ·Status: UNKNOWN

Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening

NCT01578850 ·Status: COMPLETED ·Phase: PHASE4

Microbial Dysbiosis in Rheumatoid Arthritis

NCT03802890 ·Status: UNKNOWN

Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis

NCT00579878 ·Status: COMPLETED ·Phase: PHASE3

Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)

NCT01557322 ·Status: COMPLETED

Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis

NCT02922192 ·Status: COMPLETED

A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis

NCT00976599 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists

NCT00293722 ·Status: COMPLETED

Rheumatoid Arthritis Synovial Tissue Biopsy Study

NCT07000890 ·Status: COMPLETED ·Phase: NA

Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis

NCT04582084 ·Status: COMPLETED

Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset

NCT00512239 ·Status: RECRUITING

Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria

NCT01877239 ·Status: COMPLETED

Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis

NCT00989235 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood

NCT00781469 ·Status: TERMINATED

Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)

NCT00115219 ·Status: COMPLETED ·Phase: PHASE4

To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS

NCT02311842 ·Status: COMPLETED

A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis

NCT00888745 ·Status: COMPLETED ·Phase: PHASE1

A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis

NCT00713544 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis

NCT00273858 ·Status: TERMINATED